BSECompany Update7 Aug 2026 · 7 Aug 2026, 11:48 am
Investor Presentation to be shared during Investor Meet scheduled to be held on 07th August, 2026
Mahamaya Lifesciences Ltd · 544611
✦ AI Summary
Mahamaya Lifesciences Ltd has shared its investor presentation for an investor meet scheduled on August 7, 2026, on its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mahamaya Lifesciences Ltd - 544611 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attachments (1)
📄pdf
Download →
07790eb8-8fd8-4006-bef9-ababc770a625.pdf
View document text
Date: August 07, 2026
The Listing Compliance Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai - 400 001
Scrip Code: 544611 (BSE SME)
Subject: Investor Presentation
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with Part A of Schedule III thereto, we wish to inform you that the
Investor Presentation to be shared during the Investor Meet scheduled to be held today, i.e.,
Friday, August 07, 2026, from 04:00 pm (IST) onwards is available on the Company's
website at: https://www.mahamayalifesciences.com/shareholder
The presentation is being shared for the purpose of dissemination of information and does not
contain any unpublished price sensitive information.
Kindly take the above information on record.
Thanking you
For Mahamaya Lifesciences Limited
Krishnamurthy Ganesan
Managing Director
DIN: 00270539